Sciatica Treatment Market Size to increase to USD 2.52 billion, Increasing Awareness of Sciatica to boost Market Growth - Technavio - Yahoo Finance

NEW YORK, Aug. 22nd, 2022/PRNewswire”The “Sciatica treatment market by type and Geography The “Sciatica Treatment Market by Type and Geography – Forecast and Analysis 2022-2026” report is now part of Technavio’s offerings. The growth potential difference between this sciatica treatment market from 2021 to 2026 amounts to USD 2.52 billion. To find out the exact CAGR as well as the annual growth rate for Y-O-Y, request an e-mail sample report in PDF format for free.

The most recent market research report, entitled Sciatica Treatment Market by Type and Geography – Forecast and Analysis 2022-2026 is released by Technavio that has been proudly working in partnership with Fortune 500 companies for over 16 years.

Key Market Dynamics

  • Market Factor Market Driver growing awareness of sciatica is the main driver behind the expansion in the sciatica treatments market. Awareness of the condition is growing due to efforts made by the government and non-governmental organisations. For example, HCA Healthcare UK educates individuals on symptoms of the condition, screening and diagnosis and treatments in the case of sciatica within the UK. Similar to that,, an Australian healthcare site, provides pertinent information on various health-related issues. Additionally, OrthoInfo, the American Academy of Orthopaedic Surgeons (AAOS) patient education website promotes awareness of sciatica through videos, articles and animations, both across the US.

  • Market Problem Market Challenge absence of approved treatments could hinder this sciatica treatment market over the forecast time. Patients suffering from sciatica suffer from pain along the pathway that runs through their sciatic nerve. There isn’t an medical treatment that is approved for sciatica. Treatments like NSAIDs and analgesics are able to treat just the symptoms of the disease. Additionally epidural injections of corticosteroids or physiotherapy as well as bracing can be considered to treat symptoms. Surgery is only recommended when non-surgical treatments fail. So, the absence of approved treatment options for sciatica will likely hinder the expansion of the world sciatica treatments market.

Technavio gives major drivers, trends and challenges that will shape what’s to come for this sciatica treating market. Purchase now to gain access to this data

Market Segmentation

Based on nature By type, by type, the impacts that are not surgical segment will enjoy the most market share growth over the forecast time. Non-surgical treatment options for sciatica comprise epidural non-steroidal anti-inflammatory medications (NSAIDs) corticosteroid injections, narcotics tricyclic antidepressants, muscle relaxants as well as anti-seizure medication, and physical treatments. The availability of non-prescription epidural corticosteroid shots is driving the expansion of this area. Corticosteroids are a primary treatment to treat inflammation due to sciatica.

North America will be the largest region, accounting for 37 percent of the market’s growth over the forecast time. In the US as well as Canada will be the most important countries for this sciatica treatment market within the region. The rapid growth in this region is due to factors like rising awareness of the condition as well as strategic alliances between suppliers. However, the market’s growth in this area will be slower than the markets elsewhere.

Check out our free pdf sample of the report for a deeper understanding of the contributions of all segments and opportunities for regional markets included in our sciatica treat market study.

Some companies mentioned

  • Amneal Pharmaceuticals Inc.

  • Apotex Inc.

  • Aurobindo Pharma Ltd.

  • Bayer AG

  • Dr. Reddys Laboratories Ltd.

  • Fresenius SE and Co. KGaA

  • Glenmark Pharmaceuticals Ltd.

  • Hikma Pharmaceuticals Plc

  • Johnson and Johnson

  • Lupin Ltd.

  • Nidd Valley Medical

  • Novartis AG

  • Omega Laser Systems Ltd.

  • Ozone Pharmaceuticals Ltd.

  • Pfizer Inc.

  • Sanofi

  • Sun Pharmaceutical Industries Ltd.

  • Taro Pharmaceutical Industries Ltd.

  • Teva Pharmaceutical Industries Ltd.

  • Viatris Inc.

Want your report customized? Contact an analyst to tailor your report to your requirements.

Other Reports

Celiac Diseases Drug Market according to therapy type and Geography and Forecast and analysis 2022-2026

Polycystic Kidney Disease Drugs Markets by type and Geography and Forecast and analysis 2022-2026

Sciatica Treatment Market Scope

report coverage


Number of page


Basis year


The forecast period


Growth momentum & CAGR

Decelerate at an annual rate of 4.3 percent

Market growth 2022-2026

USD 2.52 billion

The market structure


YoY Growth ( percent)


Analyse of the region

North America, Europe, Asia, and Rest of World (ROW)

A market contribution that is performed

North America at 37 percent

The most important countries for consumers

US, Canada, Australia, UK, Germany and China

Competitive landscape

Leading companies, strategies for competitiveness Consumer engagement scope

Companies profiled

Amneal Pharmaceuticals Inc., Apotex Inc., Aurobindo Pharma Ltd., Bayer AG, Dr. Reddys Laboratories Ltd., Fresenius SE and Co. KGaA, Glenmark Pharmaceuticals Ltd., Hikma Pharmaceuticals Plc, Johnson and Johnson, Lupin Ltd., Nidd Valley Medical, Novartis AG, Omega Laser Systems Ltd., Ozone Pharmaceuticals Ltd., Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., Taro Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd. as well as Viatris Inc.

Market Dynamics

Market analysis of parents Market growth inducers, market growth barriers, slow and fast-growing segment analysis, COVID-19’s impacts and future consumer dynamics as well as market conditions analysis over the period of forecast.

Customization view

The report doesn’t contain the information you’re searching for, contact our analysts to get segments that are customized.

Search Market Reports on Health Market Reports

Important Topics Included

1 Executive Summary

  • 1.1 Market overview

2. Market Landscape

  • 2.1 Market ecosystem

3 Market Sizing

  • 3.1 Market definition

  • 3.3 The size of market 2021

4. Five Forces Analysis

  • 4.1 Five forces summary

  • 4.6 The threat of competition

  • 4.7 Market conditions

5 Market Segmentation according to Type

  • 5.1 Market segments

  • 5.2 Comparison of Type

6. Customer Landscape

7 Geographical Landscape

8: Drivers, Issues and Trends

  • 8.1 Market drivers

  • 8.2 Market issues

  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview

  • 9.2 Vendor landscape

  • 9.3 Landscape disruption

  • 9.4 Risks in the industry

10 Vendor Analysis

  • 10.1 Vendors covered

  • 10.3 Apotex Inc.

  • 10.4 Bayer AG

  • 10.8 Johnson and Johnson

  • 10.9 Novartis AG

  • 10.10 Pfizer Inc.

  • 10.12 Viatris Inc.

11. Appendix

  • 11.1 The scope of this report

More About Us

Technavio is a world-class research and advisory firm in the field of technology. Their analysis and research focus on market trends that are emerging and offer practical insights to help companies identify opportunities in the market and devise efficient strategies to improve their market position.

With more than 500 analysts who specialize Technavio’s report library comprises over 17,000 report and counting, covering more than 800 technologies spread across 50 countries. Their client base is comprised of companies of all sizes, comprising more than 100 Fortune 500 companies. This expanding client base is based on Technavio’s broad coverage, thorough research and market-based insights that can be used to find opportunities in current and emerging markets, and to assess their competitive position within evolving market conditions.


Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email:[email protected]


Technavio (PRNewsfoto/Technavio)


View original content to download multimedia:—technavio-301609486.html

SOURCE Technavio